INTERNATIONAL
Upjohn to Fight UK Ban on Halcion: Upjohn Co. said it will fight a ban on sales of its sleeping drug Halcion in the United Kingdom. The sale of Halcion tablets has been suspended as of today by order of the Committee on Safety of Medicines, a regulatory authority. The committee said it has received incomplete information about the safety of the drug. Upjohn failed in an attempt to block the suspension, and the agency gave Upjohn until Nov. 8 to appeal the ruling. Although British sales account for only a minor portion of total overseas sales of Halcion, news of the British suspension drove Upjohn’s stock price down $2.125 to $44.625 in NYSE trading.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.